Atlas Trials

Study of the Safety and Immunogenicity of Reduced Doses of the US Yellow Fever Vaccine

Clinical trial NCT05374317 · COMPLETED

Trial details

NCT number
NCT05374317
Sponsor
US Army Medical Research Institute of Infectious Diseases
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Yellow Fever Vaccination Reaction
Start date
2021-06-07
Primary completion
2022-11-02
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.